Skip to Main Content

Paper Details

Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial.
Intensive Care Med
19
2022
Author NameAffiliation
Richard G WunderinkNorthwestern University Feinberg School of Medicine
Kevin C DoerschugUniv of Iowa Hosp & Clinics
  • 1 - 2

Datasets

Release 1.2